Global Aujeszky Disease Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Aujeszky Disease Vaccines market size was valued at US$ 173 million in 2025 and is forecast to a readjusted size of US$ 261 million by 2032 with a CAGR of 6.0% during review period.
Aujeszky Disease Vaccines, also known as swine pseudorabies vaccines, are veterinary biological products used to prevent pseudorabies virus infection in pigs. The product scope mainly includes live attenuated vaccines, inactivated vaccines, gene-deleted marker vaccines and combination vaccines containing pseudorabies virus antigens, with freeze-dried live vaccines and oil-emulsion inactivated vaccines as the main product forms. The most common and highest-volume strain platforms are Bartha-K61, HB98 and C strain, while JS-2012, HN1201, TP strain and HB2000 are better regarded as variant-strain or company-specific differentiated routes. Upstream inputs mainly include production strains, cell substrates, culture media, adjuvants, stabilizers, freeze-drying protectants, inactivating agents, packaging materials and cold-chain packaging. Downstream customers mainly include large-scale swine farming groups, breeding farms, commercial pig farms, veterinary drug distributors and animal disease control bodies. On an ex-factory finished-vaccine basis, global capacity in 2025 is estimated at about 2.28 billion doses, actual sales volume at about 1.64 billion doses, and the average ex-factory ASP at around USD 0.10 per dose, with an industry gross margin of about 46%–61%. Conventional Chinese live vaccines are generally priced lower, while imported marker vaccines, variant-strain inactivated vaccines and combination products carry higher equivalent ASPs.
The market for Aujeszky disease vaccines is already a mature segment within swine vaccines, with stable baseline immunization demand but clear regional differences in market activity. In parts of Europe and North America, disease eradication and monitoring systems are relatively mature, so routine commercial vaccine demand is more stable and concentrated among a limited number of multinational animal health companies. China and selected intensive swine-producing regions in Asia remain the major demand centers, as large-scale farms continue to focus on sow herd stability, piglet survival, reproductive performance and herd purification. In China, mainstream strain platforms such as Bartha-K61, HB98 and C strain still account for a large share of routine vaccination, while variant-strain inactivated vaccines, gene-deleted marker vaccines and combination vaccines are mainly used for differentiated disease-control needs.
Looking ahead, market growth will not be driven mainly by wider basic adoption, but by product upgrading, herd purification, consolidation of large-scale farms and more precise immunization programs. As integrated swine producers raise their requirements for comprehensive disease prevention, vaccine suppliers will increasingly compete through combined capabilities in vaccines, diagnostics, immunization planning and technical services. Strain matching, antigen stability, duration of immunity, batch-to-batch consistency, DIVA compatibility and compatibility with other swine vaccination programs will become more important in product evaluation. Companies with strong strain reserves, stable manufacturing processes and service capabilities for large-scale farms are likely to gain stronger positions among high-end customers and purification-oriented farms.
The main growth drivers include the expansion of intensive pig farming, normalized disease prevention, the need to improve sow productivity and demand for regional herd purification. Once pseudorabies spreads within a farm, it can cause significant production losses in breeding sows, piglets and fattening pigs, so large-scale farms usually maintain relatively stable vaccination spending. In China, integrated producers are placing higher requirements on vaccine quality, field efficacy and technical support, encouraging manufacturers to accelerate upgrades in live vaccines, inactivated vaccines, marker vaccines and combination products. Animal disease-control policies, tighter regulation of veterinary biological products, higher standards for large-scale farming and improved farm biosecurity systems also provide a long-term foundation for high-quality vaccine suppliers.
Key restraints include hog-cycle volatility, product homogenization, lower demand in purified regions and the difficulty of proving meaningful product differentiation. When farm profitability declines, some small and medium-sized farms may reduce disease-prevention budgets, affecting routine vaccine purchases. At the same time, many suppliers compete in mainstream strain platforms, creating pressure from pricing and channels. For manufacturers, variant-strain vaccines, gene-deleted marker vaccines and combination products offer upgrade potential, but they require sustained investment in research, registration, field validation and production quality control, resulting in a relatively long commercialization cycle. The market is expected to become more concentrated around companies with broader product portfolios, stable manufacturing quality, access to large farming groups and comprehensive technical service capabilities, while smaller suppliers without clear differentiation may face increasing competitive pressure.
This report is a detailed and comprehensive analysis for global Aujeszky Disease Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Aujeszky Disease Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Aujeszky Disease Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Aujeszky Disease Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Aujeszky Disease Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Aujeszky Disease Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Aujeszky Disease Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Aujeszky Disease Vaccines, with price, sales quantity, revenue, and global market share of Aujeszky Disease Vaccines from 2021 to 2026.
Chapter 3, the Aujeszky Disease Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aujeszky Disease Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Aujeszky Disease Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Aujeszky Disease Vaccines.
Chapter 14 and 15, to describe Aujeszky Disease Vaccines sales channel, distributors, customers, research findings and conclusion.
Aujeszky Disease Vaccines, also known as swine pseudorabies vaccines, are veterinary biological products used to prevent pseudorabies virus infection in pigs. The product scope mainly includes live attenuated vaccines, inactivated vaccines, gene-deleted marker vaccines and combination vaccines containing pseudorabies virus antigens, with freeze-dried live vaccines and oil-emulsion inactivated vaccines as the main product forms. The most common and highest-volume strain platforms are Bartha-K61, HB98 and C strain, while JS-2012, HN1201, TP strain and HB2000 are better regarded as variant-strain or company-specific differentiated routes. Upstream inputs mainly include production strains, cell substrates, culture media, adjuvants, stabilizers, freeze-drying protectants, inactivating agents, packaging materials and cold-chain packaging. Downstream customers mainly include large-scale swine farming groups, breeding farms, commercial pig farms, veterinary drug distributors and animal disease control bodies. On an ex-factory finished-vaccine basis, global capacity in 2025 is estimated at about 2.28 billion doses, actual sales volume at about 1.64 billion doses, and the average ex-factory ASP at around USD 0.10 per dose, with an industry gross margin of about 46%–61%. Conventional Chinese live vaccines are generally priced lower, while imported marker vaccines, variant-strain inactivated vaccines and combination products carry higher equivalent ASPs.
The market for Aujeszky disease vaccines is already a mature segment within swine vaccines, with stable baseline immunization demand but clear regional differences in market activity. In parts of Europe and North America, disease eradication and monitoring systems are relatively mature, so routine commercial vaccine demand is more stable and concentrated among a limited number of multinational animal health companies. China and selected intensive swine-producing regions in Asia remain the major demand centers, as large-scale farms continue to focus on sow herd stability, piglet survival, reproductive performance and herd purification. In China, mainstream strain platforms such as Bartha-K61, HB98 and C strain still account for a large share of routine vaccination, while variant-strain inactivated vaccines, gene-deleted marker vaccines and combination vaccines are mainly used for differentiated disease-control needs.
Looking ahead, market growth will not be driven mainly by wider basic adoption, but by product upgrading, herd purification, consolidation of large-scale farms and more precise immunization programs. As integrated swine producers raise their requirements for comprehensive disease prevention, vaccine suppliers will increasingly compete through combined capabilities in vaccines, diagnostics, immunization planning and technical services. Strain matching, antigen stability, duration of immunity, batch-to-batch consistency, DIVA compatibility and compatibility with other swine vaccination programs will become more important in product evaluation. Companies with strong strain reserves, stable manufacturing processes and service capabilities for large-scale farms are likely to gain stronger positions among high-end customers and purification-oriented farms.
The main growth drivers include the expansion of intensive pig farming, normalized disease prevention, the need to improve sow productivity and demand for regional herd purification. Once pseudorabies spreads within a farm, it can cause significant production losses in breeding sows, piglets and fattening pigs, so large-scale farms usually maintain relatively stable vaccination spending. In China, integrated producers are placing higher requirements on vaccine quality, field efficacy and technical support, encouraging manufacturers to accelerate upgrades in live vaccines, inactivated vaccines, marker vaccines and combination products. Animal disease-control policies, tighter regulation of veterinary biological products, higher standards for large-scale farming and improved farm biosecurity systems also provide a long-term foundation for high-quality vaccine suppliers.
Key restraints include hog-cycle volatility, product homogenization, lower demand in purified regions and the difficulty of proving meaningful product differentiation. When farm profitability declines, some small and medium-sized farms may reduce disease-prevention budgets, affecting routine vaccine purchases. At the same time, many suppliers compete in mainstream strain platforms, creating pressure from pricing and channels. For manufacturers, variant-strain vaccines, gene-deleted marker vaccines and combination products offer upgrade potential, but they require sustained investment in research, registration, field validation and production quality control, resulting in a relatively long commercialization cycle. The market is expected to become more concentrated around companies with broader product portfolios, stable manufacturing quality, access to large farming groups and comprehensive technical service capabilities, while smaller suppliers without clear differentiation may face increasing competitive pressure.
This report is a detailed and comprehensive analysis for global Aujeszky Disease Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Aujeszky Disease Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Aujeszky Disease Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Aujeszky Disease Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Aujeszky Disease Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Aujeszky Disease Vaccines
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Aujeszky Disease Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Live Attenuated Vaccine
- Inactivated Vaccine
- Others
- Bartha-K61 Strain
- HB98 Strain
- C Strain
- Other
- Small Pack (Below 20 Doses per Vial)
- Medium Pack (20–50 Doses per Vial)
- Large Pack (Above 50 Doses per Vial)
- Large-scale Swine Farming Groups
- Breeding Farms
- Animal Disease Control Institutions
- Others
- MSD Animal Health
- Boehringer Ingelheim
- HIPRA
- Ceva Sant? Animale
- Wuhan Keqian Biology
- Pulike Biological Engineering
- China Animal Husbandry Industry
- Jinyu Bio-Technology
- Guangdong Winsun Bio-Pharmaceutical
- Huapai Biopharm
- Jilin Zhengye Biological Products
- Sinopharm Yangzhou VAC Biological Engineering
- Sinovet Animal Health
- Jofunhwa Group
- Harbin Weike Biotechnology
- Qilu Animal Health Products
- Harbin Pharmaceutical Group Bio-vaccine
- Qingdao Yebio Bioengineering
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Aujeszky Disease Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Aujeszky Disease Vaccines, with price, sales quantity, revenue, and global market share of Aujeszky Disease Vaccines from 2021 to 2026.
Chapter 3, the Aujeszky Disease Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aujeszky Disease Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Aujeszky Disease Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Aujeszky Disease Vaccines.
Chapter 14 and 15, to describe Aujeszky Disease Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Aujeszky Disease Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Live Attenuated Vaccine
1.3.3 Inactivated Vaccine
1.3.4 Others
1.4 Market Analysis by Strain Platform
1.4.1 Overview: Global Aujeszky Disease Vaccines Consumption Value by Strain Platform: 2021 Versus 2025 Versus 2032
1.4.2 Bartha-K61 Strain
1.4.3 HB98 Strain
1.4.4 C Strain
1.4.5 Other
1.5 Market Analysis by Dose Pack Size
1.5.1 Overview: Global Aujeszky Disease Vaccines Consumption Value by Dose Pack Size: 2021 Versus 2025 Versus 2032
1.5.2 Small Pack (Below 20 Doses per Vial)
1.5.3 Medium Pack (20–50 Doses per Vial)
1.5.4 Large Pack (Above 50 Doses per Vial)
1.6 Market Analysis by Application
1.6.1 Overview: Global Aujeszky Disease Vaccines Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Large-scale Swine Farming Groups
1.6.3 Breeding Farms
1.6.4 Animal Disease Control Institutions
1.6.5 Others
1.7 Global Aujeszky Disease Vaccines Market Size & Forecast
1.7.1 Global Aujeszky Disease Vaccines Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Aujeszky Disease Vaccines Sales Quantity (2021-2032)
1.7.3 Global Aujeszky Disease Vaccines Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 MSD Animal Health
2.1.1 MSD Animal Health Details
2.1.2 MSD Animal Health Major Business
2.1.3 MSD Animal Health Aujeszky Disease Vaccines Product and Services
2.1.4 MSD Animal Health Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 MSD Animal Health Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Aujeszky Disease Vaccines Product and Services
2.2.4 Boehringer Ingelheim Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 HIPRA
2.3.1 HIPRA Details
2.3.2 HIPRA Major Business
2.3.3 HIPRA Aujeszky Disease Vaccines Product and Services
2.3.4 HIPRA Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 HIPRA Recent Developments/Updates
2.4 Ceva Sant? Animale
2.4.1 Ceva Sant? Animale Details
2.4.2 Ceva Sant? Animale Major Business
2.4.3 Ceva Sant? Animale Aujeszky Disease Vaccines Product and Services
2.4.4 Ceva Sant? Animale Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Ceva Sant? Animale Recent Developments/Updates
2.5 Wuhan Keqian Biology
2.5.1 Wuhan Keqian Biology Details
2.5.2 Wuhan Keqian Biology Major Business
2.5.3 Wuhan Keqian Biology Aujeszky Disease Vaccines Product and Services
2.5.4 Wuhan Keqian Biology Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Wuhan Keqian Biology Recent Developments/Updates
2.6 Pulike Biological Engineering
2.6.1 Pulike Biological Engineering Details
2.6.2 Pulike Biological Engineering Major Business
2.6.3 Pulike Biological Engineering Aujeszky Disease Vaccines Product and Services
2.6.4 Pulike Biological Engineering Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Pulike Biological Engineering Recent Developments/Updates
2.7 China Animal Husbandry Industry
2.7.1 China Animal Husbandry Industry Details
2.7.2 China Animal Husbandry Industry Major Business
2.7.3 China Animal Husbandry Industry Aujeszky Disease Vaccines Product and Services
2.7.4 China Animal Husbandry Industry Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 China Animal Husbandry Industry Recent Developments/Updates
2.8 Jinyu Bio-Technology
2.8.1 Jinyu Bio-Technology Details
2.8.2 Jinyu Bio-Technology Major Business
2.8.3 Jinyu Bio-Technology Aujeszky Disease Vaccines Product and Services
2.8.4 Jinyu Bio-Technology Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Jinyu Bio-Technology Recent Developments/Updates
2.9 Guangdong Winsun Bio-Pharmaceutical
2.9.1 Guangdong Winsun Bio-Pharmaceutical Details
2.9.2 Guangdong Winsun Bio-Pharmaceutical Major Business
2.9.3 Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Product and Services
2.9.4 Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
2.10 Huapai Biopharm
2.10.1 Huapai Biopharm Details
2.10.2 Huapai Biopharm Major Business
2.10.3 Huapai Biopharm Aujeszky Disease Vaccines Product and Services
2.10.4 Huapai Biopharm Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Huapai Biopharm Recent Developments/Updates
2.11 Jilin Zhengye Biological Products
2.11.1 Jilin Zhengye Biological Products Details
2.11.2 Jilin Zhengye Biological Products Major Business
2.11.3 Jilin Zhengye Biological Products Aujeszky Disease Vaccines Product and Services
2.11.4 Jilin Zhengye Biological Products Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Jilin Zhengye Biological Products Recent Developments/Updates
2.12 Sinopharm Yangzhou VAC Biological Engineering
2.12.1 Sinopharm Yangzhou VAC Biological Engineering Details
2.12.2 Sinopharm Yangzhou VAC Biological Engineering Major Business
2.12.3 Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Product and Services
2.12.4 Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Sinopharm Yangzhou VAC Biological Engineering Recent Developments/Updates
2.13 Sinovet Animal Health
2.13.1 Sinovet Animal Health Details
2.13.2 Sinovet Animal Health Major Business
2.13.3 Sinovet Animal Health Aujeszky Disease Vaccines Product and Services
2.13.4 Sinovet Animal Health Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Sinovet Animal Health Recent Developments/Updates
2.14 Jofunhwa Group
2.14.1 Jofunhwa Group Details
2.14.2 Jofunhwa Group Major Business
2.14.3 Jofunhwa Group Aujeszky Disease Vaccines Product and Services
2.14.4 Jofunhwa Group Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Jofunhwa Group Recent Developments/Updates
2.15 Harbin Weike Biotechnology
2.15.1 Harbin Weike Biotechnology Details
2.15.2 Harbin Weike Biotechnology Major Business
2.15.3 Harbin Weike Biotechnology Aujeszky Disease Vaccines Product and Services
2.15.4 Harbin Weike Biotechnology Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Harbin Weike Biotechnology Recent Developments/Updates
2.16 Qilu Animal Health Products
2.16.1 Qilu Animal Health Products Details
2.16.2 Qilu Animal Health Products Major Business
2.16.3 Qilu Animal Health Products Aujeszky Disease Vaccines Product and Services
2.16.4 Qilu Animal Health Products Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Qilu Animal Health Products Recent Developments/Updates
2.17 Harbin Pharmaceutical Group Bio-vaccine
2.17.1 Harbin Pharmaceutical Group Bio-vaccine Details
2.17.2 Harbin Pharmaceutical Group Bio-vaccine Major Business
2.17.3 Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Product and Services
2.17.4 Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
2.18 Qingdao Yebio Bioengineering
2.18.1 Qingdao Yebio Bioengineering Details
2.18.2 Qingdao Yebio Bioengineering Major Business
2.18.3 Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Product and Services
2.18.4 Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Qingdao Yebio Bioengineering Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: AUJESZKY DISEASE VACCINES BY MANUFACTURER
3.1 Global Aujeszky Disease Vaccines Sales Quantity by Manufacturer (2021-2026)
3.2 Global Aujeszky Disease Vaccines Revenue by Manufacturer (2021-2026)
3.3 Global Aujeszky Disease Vaccines Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Aujeszky Disease Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Aujeszky Disease Vaccines Manufacturer Market Share in 2025
3.4.3 Top 6 Aujeszky Disease Vaccines Manufacturer Market Share in 2025
3.5 Aujeszky Disease Vaccines Market: Overall Company Footprint Analysis
3.5.1 Aujeszky Disease Vaccines Market: Region Footprint
3.5.2 Aujeszky Disease Vaccines Market: Company Product Type Footprint
3.5.3 Aujeszky Disease Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Aujeszky Disease Vaccines Market Size by Region
4.1.1 Global Aujeszky Disease Vaccines Sales Quantity by Region (2021-2032)
4.1.2 Global Aujeszky Disease Vaccines Consumption Value by Region (2021-2032)
4.1.3 Global Aujeszky Disease Vaccines Average Price by Region (2021-2032)
4.2 North America Aujeszky Disease Vaccines Consumption Value (2021-2032)
4.3 Europe Aujeszky Disease Vaccines Consumption Value (2021-2032)
4.4 Asia-Pacific Aujeszky Disease Vaccines Consumption Value (2021-2032)
4.5 South America Aujeszky Disease Vaccines Consumption Value (2021-2032)
4.6 Middle East & Africa Aujeszky Disease Vaccines Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Aujeszky Disease Vaccines Sales Quantity by Type (2021-2032)
5.2 Global Aujeszky Disease Vaccines Consumption Value by Type (2021-2032)
5.3 Global Aujeszky Disease Vaccines Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Aujeszky Disease Vaccines Sales Quantity by Application (2021-2032)
6.2 Global Aujeszky Disease Vaccines Consumption Value by Application (2021-2032)
6.3 Global Aujeszky Disease Vaccines Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Aujeszky Disease Vaccines Sales Quantity by Type (2021-2032)
7.2 North America Aujeszky Disease Vaccines Sales Quantity by Application (2021-2032)
7.3 North America Aujeszky Disease Vaccines Market Size by Country
7.3.1 North America Aujeszky Disease Vaccines Sales Quantity by Country (2021-2032)
7.3.2 North America Aujeszky Disease Vaccines Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Aujeszky Disease Vaccines Sales Quantity by Type (2021-2032)
8.2 Europe Aujeszky Disease Vaccines Sales Quantity by Application (2021-2032)
8.3 Europe Aujeszky Disease Vaccines Market Size by Country
8.3.1 Europe Aujeszky Disease Vaccines Sales Quantity by Country (2021-2032)
8.3.2 Europe Aujeszky Disease Vaccines Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Aujeszky Disease Vaccines Market Size by Region
9.3.1 Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Aujeszky Disease Vaccines Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Aujeszky Disease Vaccines Sales Quantity by Type (2021-2032)
10.2 South America Aujeszky Disease Vaccines Sales Quantity by Application (2021-2032)
10.3 South America Aujeszky Disease Vaccines Market Size by Country
10.3.1 South America Aujeszky Disease Vaccines Sales Quantity by Country (2021-2032)
10.3.2 South America Aujeszky Disease Vaccines Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Aujeszky Disease Vaccines Market Size by Country
11.3.1 Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Aujeszky Disease Vaccines Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Aujeszky Disease Vaccines Market Drivers
12.2 Aujeszky Disease Vaccines Market Restraints
12.3 Aujeszky Disease Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Aujeszky Disease Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Aujeszky Disease Vaccines
13.3 Aujeszky Disease Vaccines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Aujeszky Disease Vaccines Typical Distributors
14.3 Aujeszky Disease Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Aujeszky Disease Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Live Attenuated Vaccine
1.3.3 Inactivated Vaccine
1.3.4 Others
1.4 Market Analysis by Strain Platform
1.4.1 Overview: Global Aujeszky Disease Vaccines Consumption Value by Strain Platform: 2021 Versus 2025 Versus 2032
1.4.2 Bartha-K61 Strain
1.4.3 HB98 Strain
1.4.4 C Strain
1.4.5 Other
1.5 Market Analysis by Dose Pack Size
1.5.1 Overview: Global Aujeszky Disease Vaccines Consumption Value by Dose Pack Size: 2021 Versus 2025 Versus 2032
1.5.2 Small Pack (Below 20 Doses per Vial)
1.5.3 Medium Pack (20–50 Doses per Vial)
1.5.4 Large Pack (Above 50 Doses per Vial)
1.6 Market Analysis by Application
1.6.1 Overview: Global Aujeszky Disease Vaccines Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Large-scale Swine Farming Groups
1.6.3 Breeding Farms
1.6.4 Animal Disease Control Institutions
1.6.5 Others
1.7 Global Aujeszky Disease Vaccines Market Size & Forecast
1.7.1 Global Aujeszky Disease Vaccines Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Aujeszky Disease Vaccines Sales Quantity (2021-2032)
1.7.3 Global Aujeszky Disease Vaccines Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 MSD Animal Health
2.1.1 MSD Animal Health Details
2.1.2 MSD Animal Health Major Business
2.1.3 MSD Animal Health Aujeszky Disease Vaccines Product and Services
2.1.4 MSD Animal Health Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 MSD Animal Health Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Aujeszky Disease Vaccines Product and Services
2.2.4 Boehringer Ingelheim Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 HIPRA
2.3.1 HIPRA Details
2.3.2 HIPRA Major Business
2.3.3 HIPRA Aujeszky Disease Vaccines Product and Services
2.3.4 HIPRA Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 HIPRA Recent Developments/Updates
2.4 Ceva Sant? Animale
2.4.1 Ceva Sant? Animale Details
2.4.2 Ceva Sant? Animale Major Business
2.4.3 Ceva Sant? Animale Aujeszky Disease Vaccines Product and Services
2.4.4 Ceva Sant? Animale Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Ceva Sant? Animale Recent Developments/Updates
2.5 Wuhan Keqian Biology
2.5.1 Wuhan Keqian Biology Details
2.5.2 Wuhan Keqian Biology Major Business
2.5.3 Wuhan Keqian Biology Aujeszky Disease Vaccines Product and Services
2.5.4 Wuhan Keqian Biology Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Wuhan Keqian Biology Recent Developments/Updates
2.6 Pulike Biological Engineering
2.6.1 Pulike Biological Engineering Details
2.6.2 Pulike Biological Engineering Major Business
2.6.3 Pulike Biological Engineering Aujeszky Disease Vaccines Product and Services
2.6.4 Pulike Biological Engineering Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Pulike Biological Engineering Recent Developments/Updates
2.7 China Animal Husbandry Industry
2.7.1 China Animal Husbandry Industry Details
2.7.2 China Animal Husbandry Industry Major Business
2.7.3 China Animal Husbandry Industry Aujeszky Disease Vaccines Product and Services
2.7.4 China Animal Husbandry Industry Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 China Animal Husbandry Industry Recent Developments/Updates
2.8 Jinyu Bio-Technology
2.8.1 Jinyu Bio-Technology Details
2.8.2 Jinyu Bio-Technology Major Business
2.8.3 Jinyu Bio-Technology Aujeszky Disease Vaccines Product and Services
2.8.4 Jinyu Bio-Technology Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Jinyu Bio-Technology Recent Developments/Updates
2.9 Guangdong Winsun Bio-Pharmaceutical
2.9.1 Guangdong Winsun Bio-Pharmaceutical Details
2.9.2 Guangdong Winsun Bio-Pharmaceutical Major Business
2.9.3 Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Product and Services
2.9.4 Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
2.10 Huapai Biopharm
2.10.1 Huapai Biopharm Details
2.10.2 Huapai Biopharm Major Business
2.10.3 Huapai Biopharm Aujeszky Disease Vaccines Product and Services
2.10.4 Huapai Biopharm Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Huapai Biopharm Recent Developments/Updates
2.11 Jilin Zhengye Biological Products
2.11.1 Jilin Zhengye Biological Products Details
2.11.2 Jilin Zhengye Biological Products Major Business
2.11.3 Jilin Zhengye Biological Products Aujeszky Disease Vaccines Product and Services
2.11.4 Jilin Zhengye Biological Products Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Jilin Zhengye Biological Products Recent Developments/Updates
2.12 Sinopharm Yangzhou VAC Biological Engineering
2.12.1 Sinopharm Yangzhou VAC Biological Engineering Details
2.12.2 Sinopharm Yangzhou VAC Biological Engineering Major Business
2.12.3 Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Product and Services
2.12.4 Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Sinopharm Yangzhou VAC Biological Engineering Recent Developments/Updates
2.13 Sinovet Animal Health
2.13.1 Sinovet Animal Health Details
2.13.2 Sinovet Animal Health Major Business
2.13.3 Sinovet Animal Health Aujeszky Disease Vaccines Product and Services
2.13.4 Sinovet Animal Health Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Sinovet Animal Health Recent Developments/Updates
2.14 Jofunhwa Group
2.14.1 Jofunhwa Group Details
2.14.2 Jofunhwa Group Major Business
2.14.3 Jofunhwa Group Aujeszky Disease Vaccines Product and Services
2.14.4 Jofunhwa Group Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Jofunhwa Group Recent Developments/Updates
2.15 Harbin Weike Biotechnology
2.15.1 Harbin Weike Biotechnology Details
2.15.2 Harbin Weike Biotechnology Major Business
2.15.3 Harbin Weike Biotechnology Aujeszky Disease Vaccines Product and Services
2.15.4 Harbin Weike Biotechnology Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Harbin Weike Biotechnology Recent Developments/Updates
2.16 Qilu Animal Health Products
2.16.1 Qilu Animal Health Products Details
2.16.2 Qilu Animal Health Products Major Business
2.16.3 Qilu Animal Health Products Aujeszky Disease Vaccines Product and Services
2.16.4 Qilu Animal Health Products Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Qilu Animal Health Products Recent Developments/Updates
2.17 Harbin Pharmaceutical Group Bio-vaccine
2.17.1 Harbin Pharmaceutical Group Bio-vaccine Details
2.17.2 Harbin Pharmaceutical Group Bio-vaccine Major Business
2.17.3 Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Product and Services
2.17.4 Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
2.18 Qingdao Yebio Bioengineering
2.18.1 Qingdao Yebio Bioengineering Details
2.18.2 Qingdao Yebio Bioengineering Major Business
2.18.3 Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Product and Services
2.18.4 Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Qingdao Yebio Bioengineering Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: AUJESZKY DISEASE VACCINES BY MANUFACTURER
3.1 Global Aujeszky Disease Vaccines Sales Quantity by Manufacturer (2021-2026)
3.2 Global Aujeszky Disease Vaccines Revenue by Manufacturer (2021-2026)
3.3 Global Aujeszky Disease Vaccines Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Aujeszky Disease Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Aujeszky Disease Vaccines Manufacturer Market Share in 2025
3.4.3 Top 6 Aujeszky Disease Vaccines Manufacturer Market Share in 2025
3.5 Aujeszky Disease Vaccines Market: Overall Company Footprint Analysis
3.5.1 Aujeszky Disease Vaccines Market: Region Footprint
3.5.2 Aujeszky Disease Vaccines Market: Company Product Type Footprint
3.5.3 Aujeszky Disease Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Aujeszky Disease Vaccines Market Size by Region
4.1.1 Global Aujeszky Disease Vaccines Sales Quantity by Region (2021-2032)
4.1.2 Global Aujeszky Disease Vaccines Consumption Value by Region (2021-2032)
4.1.3 Global Aujeszky Disease Vaccines Average Price by Region (2021-2032)
4.2 North America Aujeszky Disease Vaccines Consumption Value (2021-2032)
4.3 Europe Aujeszky Disease Vaccines Consumption Value (2021-2032)
4.4 Asia-Pacific Aujeszky Disease Vaccines Consumption Value (2021-2032)
4.5 South America Aujeszky Disease Vaccines Consumption Value (2021-2032)
4.6 Middle East & Africa Aujeszky Disease Vaccines Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Aujeszky Disease Vaccines Sales Quantity by Type (2021-2032)
5.2 Global Aujeszky Disease Vaccines Consumption Value by Type (2021-2032)
5.3 Global Aujeszky Disease Vaccines Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Aujeszky Disease Vaccines Sales Quantity by Application (2021-2032)
6.2 Global Aujeszky Disease Vaccines Consumption Value by Application (2021-2032)
6.3 Global Aujeszky Disease Vaccines Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Aujeszky Disease Vaccines Sales Quantity by Type (2021-2032)
7.2 North America Aujeszky Disease Vaccines Sales Quantity by Application (2021-2032)
7.3 North America Aujeszky Disease Vaccines Market Size by Country
7.3.1 North America Aujeszky Disease Vaccines Sales Quantity by Country (2021-2032)
7.3.2 North America Aujeszky Disease Vaccines Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Aujeszky Disease Vaccines Sales Quantity by Type (2021-2032)
8.2 Europe Aujeszky Disease Vaccines Sales Quantity by Application (2021-2032)
8.3 Europe Aujeszky Disease Vaccines Market Size by Country
8.3.1 Europe Aujeszky Disease Vaccines Sales Quantity by Country (2021-2032)
8.3.2 Europe Aujeszky Disease Vaccines Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Aujeszky Disease Vaccines Market Size by Region
9.3.1 Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Aujeszky Disease Vaccines Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Aujeszky Disease Vaccines Sales Quantity by Type (2021-2032)
10.2 South America Aujeszky Disease Vaccines Sales Quantity by Application (2021-2032)
10.3 South America Aujeszky Disease Vaccines Market Size by Country
10.3.1 South America Aujeszky Disease Vaccines Sales Quantity by Country (2021-2032)
10.3.2 South America Aujeszky Disease Vaccines Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Aujeszky Disease Vaccines Market Size by Country
11.3.1 Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Aujeszky Disease Vaccines Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Aujeszky Disease Vaccines Market Drivers
12.2 Aujeszky Disease Vaccines Market Restraints
12.3 Aujeszky Disease Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Aujeszky Disease Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Aujeszky Disease Vaccines
13.3 Aujeszky Disease Vaccines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Aujeszky Disease Vaccines Typical Distributors
14.3 Aujeszky Disease Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Aujeszky Disease Vaccines Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Aujeszky Disease Vaccines Consumption Value by Strain Platform, (USD Million), 2021 & 2025 & 2032
Table 3. Global Aujeszky Disease Vaccines Consumption Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Table 4. Global Aujeszky Disease Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 6. MSD Animal Health Major Business
Table 7. MSD Animal Health Aujeszky Disease Vaccines Product and Services
Table 8. MSD Animal Health Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. MSD Animal Health Recent Developments/Updates
Table 10. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 11. Boehringer Ingelheim Major Business
Table 12. Boehringer Ingelheim Aujeszky Disease Vaccines Product and Services
Table 13. Boehringer Ingelheim Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Boehringer Ingelheim Recent Developments/Updates
Table 15. HIPRA Basic Information, Manufacturing Base and Competitors
Table 16. HIPRA Major Business
Table 17. HIPRA Aujeszky Disease Vaccines Product and Services
Table 18. HIPRA Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. HIPRA Recent Developments/Updates
Table 20. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 21. Ceva Sant? Animale Major Business
Table 22. Ceva Sant? Animale Aujeszky Disease Vaccines Product and Services
Table 23. Ceva Sant? Animale Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Ceva Sant? Animale Recent Developments/Updates
Table 25. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 26. Wuhan Keqian Biology Major Business
Table 27. Wuhan Keqian Biology Aujeszky Disease Vaccines Product and Services
Table 28. Wuhan Keqian Biology Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Wuhan Keqian Biology Recent Developments/Updates
Table 30. Pulike Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 31. Pulike Biological Engineering Major Business
Table 32. Pulike Biological Engineering Aujeszky Disease Vaccines Product and Services
Table 33. Pulike Biological Engineering Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Pulike Biological Engineering Recent Developments/Updates
Table 35. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 36. China Animal Husbandry Industry Major Business
Table 37. China Animal Husbandry Industry Aujeszky Disease Vaccines Product and Services
Table 38. China Animal Husbandry Industry Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. China Animal Husbandry Industry Recent Developments/Updates
Table 40. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 41. Jinyu Bio-Technology Major Business
Table 42. Jinyu Bio-Technology Aujeszky Disease Vaccines Product and Services
Table 43. Jinyu Bio-Technology Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Jinyu Bio-Technology Recent Developments/Updates
Table 45. Guangdong Winsun Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 46. Guangdong Winsun Bio-Pharmaceutical Major Business
Table 47. Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Product and Services
Table 48. Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
Table 50. Huapai Biopharm Basic Information, Manufacturing Base and Competitors
Table 51. Huapai Biopharm Major Business
Table 52. Huapai Biopharm Aujeszky Disease Vaccines Product and Services
Table 53. Huapai Biopharm Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Huapai Biopharm Recent Developments/Updates
Table 55. Jilin Zhengye Biological Products Basic Information, Manufacturing Base and Competitors
Table 56. Jilin Zhengye Biological Products Major Business
Table 57. Jilin Zhengye Biological Products Aujeszky Disease Vaccines Product and Services
Table 58. Jilin Zhengye Biological Products Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Jilin Zhengye Biological Products Recent Developments/Updates
Table 60. Sinopharm Yangzhou VAC Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 61. Sinopharm Yangzhou VAC Biological Engineering Major Business
Table 62. Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Product and Services
Table 63. Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Sinopharm Yangzhou VAC Biological Engineering Recent Developments/Updates
Table 65. Sinovet Animal Health Basic Information, Manufacturing Base and Competitors
Table 66. Sinovet Animal Health Major Business
Table 67. Sinovet Animal Health Aujeszky Disease Vaccines Product and Services
Table 68. Sinovet Animal Health Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Sinovet Animal Health Recent Developments/Updates
Table 70. Jofunhwa Group Basic Information, Manufacturing Base and Competitors
Table 71. Jofunhwa Group Major Business
Table 72. Jofunhwa Group Aujeszky Disease Vaccines Product and Services
Table 73. Jofunhwa Group Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Jofunhwa Group Recent Developments/Updates
Table 75. Harbin Weike Biotechnology Basic Information, Manufacturing Base and Competitors
Table 76. Harbin Weike Biotechnology Major Business
Table 77. Harbin Weike Biotechnology Aujeszky Disease Vaccines Product and Services
Table 78. Harbin Weike Biotechnology Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Harbin Weike Biotechnology Recent Developments/Updates
Table 80. Qilu Animal Health Products Basic Information, Manufacturing Base and Competitors
Table 81. Qilu Animal Health Products Major Business
Table 82. Qilu Animal Health Products Aujeszky Disease Vaccines Product and Services
Table 83. Qilu Animal Health Products Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Qilu Animal Health Products Recent Developments/Updates
Table 85. Harbin Pharmaceutical Group Bio-vaccine Basic Information, Manufacturing Base and Competitors
Table 86. Harbin Pharmaceutical Group Bio-vaccine Major Business
Table 87. Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Product and Services
Table 88. Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
Table 90. Qingdao Yebio Bioengineering Basic Information, Manufacturing Base and Competitors
Table 91. Qingdao Yebio Bioengineering Major Business
Table 92. Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Product and Services
Table 93. Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Qingdao Yebio Bioengineering Recent Developments/Updates
Table 95. Global Aujeszky Disease Vaccines Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 96. Global Aujeszky Disease Vaccines Revenue by Manufacturer (2021-2026) & (USD Million)
Table 97. Global Aujeszky Disease Vaccines Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 98. Market Position of Manufacturers in Aujeszky Disease Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 99. Head Office and Aujeszky Disease Vaccines Production Site of Key Manufacturer
Table 100. Aujeszky Disease Vaccines Market: Company Product Type Footprint
Table 101. Aujeszky Disease Vaccines Market: Company Product Application Footprint
Table 102. Aujeszky Disease Vaccines New Market Entrants and Barriers to Market Entry
Table 103. Aujeszky Disease Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Aujeszky Disease Vaccines Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 105. Global Aujeszky Disease Vaccines Sales Quantity by Region (2021-2026) & (K Dose)
Table 106. Global Aujeszky Disease Vaccines Sales Quantity by Region (2027-2032) & (K Dose)
Table 107. Global Aujeszky Disease Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 108. Global Aujeszky Disease Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 109. Global Aujeszky Disease Vaccines Average Price by Region (2021-2026) & (US$/Dose)
Table 110. Global Aujeszky Disease Vaccines Average Price by Region (2027-2032) & (US$/Dose)
Table 111. Global Aujeszky Disease Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 112. Global Aujeszky Disease Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 113. Global Aujeszky Disease Vaccines Consumption Value by Type (2021-2026) & (USD Million)
Table 114. Global Aujeszky Disease Vaccines Consumption Value by Type (2027-2032) & (USD Million)
Table 115. Global Aujeszky Disease Vaccines Average Price by Type (2021-2026) & (US$/Dose)
Table 116. Global Aujeszky Disease Vaccines Average Price by Type (2027-2032) & (US$/Dose)
Table 117. Global Aujeszky Disease Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 118. Global Aujeszky Disease Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 119. Global Aujeszky Disease Vaccines Consumption Value by Application (2021-2026) & (USD Million)
Table 120. Global Aujeszky Disease Vaccines Consumption Value by Application (2027-2032) & (USD Million)
Table 121. Global Aujeszky Disease Vaccines Average Price by Application (2021-2026) & (US$/Dose)
Table 122. Global Aujeszky Disease Vaccines Average Price by Application (2027-2032) & (US$/Dose)
Table 123. North America Aujeszky Disease Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 124. North America Aujeszky Disease Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 125. North America Aujeszky Disease Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 126. North America Aujeszky Disease Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 127. North America Aujeszky Disease Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 128. North America Aujeszky Disease Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 129. North America Aujeszky Disease Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 130. North America Aujeszky Disease Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 131. Europe Aujeszky Disease Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 132. Europe Aujeszky Disease Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 133. Europe Aujeszky Disease Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 134. Europe Aujeszky Disease Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 135. Europe Aujeszky Disease Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 136. Europe Aujeszky Disease Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 137. Europe Aujeszky Disease Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 138. Europe Aujeszky Disease Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 140. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 141. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 142. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 143. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Region (2021-2026) & (K Dose)
Table 144. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Region (2027-2032) & (K Dose)
Table 145. Asia-Pacific Aujeszky Disease Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 146. Asia-Pacific Aujeszky Disease Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 147. South America Aujeszky Disease Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 148. South America Aujeszky Disease Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 149. South America Aujeszky Disease Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 150. South America Aujeszky Disease Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 151. South America Aujeszky Disease Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 152. South America Aujeszky Disease Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 153. South America Aujeszky Disease Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 154. South America Aujeszky Disease Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 155. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 156. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 157. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 158. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 159. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 160. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 161. Middle East & Africa Aujeszky Disease Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 162. Middle East & Africa Aujeszky Disease Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 163. Aujeszky Disease Vaccines Raw Material
Table 164. Key Manufacturers of Aujeszky Disease Vaccines Raw Materials
Table 165. Aujeszky Disease Vaccines Typical Distributors
Table 166. Aujeszky Disease Vaccines Typical Customers
Table 1. Global Aujeszky Disease Vaccines Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Aujeszky Disease Vaccines Consumption Value by Strain Platform, (USD Million), 2021 & 2025 & 2032
Table 3. Global Aujeszky Disease Vaccines Consumption Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Table 4. Global Aujeszky Disease Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 6. MSD Animal Health Major Business
Table 7. MSD Animal Health Aujeszky Disease Vaccines Product and Services
Table 8. MSD Animal Health Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. MSD Animal Health Recent Developments/Updates
Table 10. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 11. Boehringer Ingelheim Major Business
Table 12. Boehringer Ingelheim Aujeszky Disease Vaccines Product and Services
Table 13. Boehringer Ingelheim Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Boehringer Ingelheim Recent Developments/Updates
Table 15. HIPRA Basic Information, Manufacturing Base and Competitors
Table 16. HIPRA Major Business
Table 17. HIPRA Aujeszky Disease Vaccines Product and Services
Table 18. HIPRA Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. HIPRA Recent Developments/Updates
Table 20. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 21. Ceva Sant? Animale Major Business
Table 22. Ceva Sant? Animale Aujeszky Disease Vaccines Product and Services
Table 23. Ceva Sant? Animale Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Ceva Sant? Animale Recent Developments/Updates
Table 25. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 26. Wuhan Keqian Biology Major Business
Table 27. Wuhan Keqian Biology Aujeszky Disease Vaccines Product and Services
Table 28. Wuhan Keqian Biology Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Wuhan Keqian Biology Recent Developments/Updates
Table 30. Pulike Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 31. Pulike Biological Engineering Major Business
Table 32. Pulike Biological Engineering Aujeszky Disease Vaccines Product and Services
Table 33. Pulike Biological Engineering Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Pulike Biological Engineering Recent Developments/Updates
Table 35. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 36. China Animal Husbandry Industry Major Business
Table 37. China Animal Husbandry Industry Aujeszky Disease Vaccines Product and Services
Table 38. China Animal Husbandry Industry Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. China Animal Husbandry Industry Recent Developments/Updates
Table 40. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 41. Jinyu Bio-Technology Major Business
Table 42. Jinyu Bio-Technology Aujeszky Disease Vaccines Product and Services
Table 43. Jinyu Bio-Technology Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Jinyu Bio-Technology Recent Developments/Updates
Table 45. Guangdong Winsun Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 46. Guangdong Winsun Bio-Pharmaceutical Major Business
Table 47. Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Product and Services
Table 48. Guangdong Winsun Bio-Pharmaceutical Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Guangdong Winsun Bio-Pharmaceutical Recent Developments/Updates
Table 50. Huapai Biopharm Basic Information, Manufacturing Base and Competitors
Table 51. Huapai Biopharm Major Business
Table 52. Huapai Biopharm Aujeszky Disease Vaccines Product and Services
Table 53. Huapai Biopharm Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Huapai Biopharm Recent Developments/Updates
Table 55. Jilin Zhengye Biological Products Basic Information, Manufacturing Base and Competitors
Table 56. Jilin Zhengye Biological Products Major Business
Table 57. Jilin Zhengye Biological Products Aujeszky Disease Vaccines Product and Services
Table 58. Jilin Zhengye Biological Products Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Jilin Zhengye Biological Products Recent Developments/Updates
Table 60. Sinopharm Yangzhou VAC Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 61. Sinopharm Yangzhou VAC Biological Engineering Major Business
Table 62. Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Product and Services
Table 63. Sinopharm Yangzhou VAC Biological Engineering Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Sinopharm Yangzhou VAC Biological Engineering Recent Developments/Updates
Table 65. Sinovet Animal Health Basic Information, Manufacturing Base and Competitors
Table 66. Sinovet Animal Health Major Business
Table 67. Sinovet Animal Health Aujeszky Disease Vaccines Product and Services
Table 68. Sinovet Animal Health Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Sinovet Animal Health Recent Developments/Updates
Table 70. Jofunhwa Group Basic Information, Manufacturing Base and Competitors
Table 71. Jofunhwa Group Major Business
Table 72. Jofunhwa Group Aujeszky Disease Vaccines Product and Services
Table 73. Jofunhwa Group Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Jofunhwa Group Recent Developments/Updates
Table 75. Harbin Weike Biotechnology Basic Information, Manufacturing Base and Competitors
Table 76. Harbin Weike Biotechnology Major Business
Table 77. Harbin Weike Biotechnology Aujeszky Disease Vaccines Product and Services
Table 78. Harbin Weike Biotechnology Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Harbin Weike Biotechnology Recent Developments/Updates
Table 80. Qilu Animal Health Products Basic Information, Manufacturing Base and Competitors
Table 81. Qilu Animal Health Products Major Business
Table 82. Qilu Animal Health Products Aujeszky Disease Vaccines Product and Services
Table 83. Qilu Animal Health Products Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Qilu Animal Health Products Recent Developments/Updates
Table 85. Harbin Pharmaceutical Group Bio-vaccine Basic Information, Manufacturing Base and Competitors
Table 86. Harbin Pharmaceutical Group Bio-vaccine Major Business
Table 87. Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Product and Services
Table 88. Harbin Pharmaceutical Group Bio-vaccine Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
Table 90. Qingdao Yebio Bioengineering Basic Information, Manufacturing Base and Competitors
Table 91. Qingdao Yebio Bioengineering Major Business
Table 92. Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Product and Services
Table 93. Qingdao Yebio Bioengineering Aujeszky Disease Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Qingdao Yebio Bioengineering Recent Developments/Updates
Table 95. Global Aujeszky Disease Vaccines Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 96. Global Aujeszky Disease Vaccines Revenue by Manufacturer (2021-2026) & (USD Million)
Table 97. Global Aujeszky Disease Vaccines Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 98. Market Position of Manufacturers in Aujeszky Disease Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 99. Head Office and Aujeszky Disease Vaccines Production Site of Key Manufacturer
Table 100. Aujeszky Disease Vaccines Market: Company Product Type Footprint
Table 101. Aujeszky Disease Vaccines Market: Company Product Application Footprint
Table 102. Aujeszky Disease Vaccines New Market Entrants and Barriers to Market Entry
Table 103. Aujeszky Disease Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Aujeszky Disease Vaccines Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 105. Global Aujeszky Disease Vaccines Sales Quantity by Region (2021-2026) & (K Dose)
Table 106. Global Aujeszky Disease Vaccines Sales Quantity by Region (2027-2032) & (K Dose)
Table 107. Global Aujeszky Disease Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 108. Global Aujeszky Disease Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 109. Global Aujeszky Disease Vaccines Average Price by Region (2021-2026) & (US$/Dose)
Table 110. Global Aujeszky Disease Vaccines Average Price by Region (2027-2032) & (US$/Dose)
Table 111. Global Aujeszky Disease Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 112. Global Aujeszky Disease Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 113. Global Aujeszky Disease Vaccines Consumption Value by Type (2021-2026) & (USD Million)
Table 114. Global Aujeszky Disease Vaccines Consumption Value by Type (2027-2032) & (USD Million)
Table 115. Global Aujeszky Disease Vaccines Average Price by Type (2021-2026) & (US$/Dose)
Table 116. Global Aujeszky Disease Vaccines Average Price by Type (2027-2032) & (US$/Dose)
Table 117. Global Aujeszky Disease Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 118. Global Aujeszky Disease Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 119. Global Aujeszky Disease Vaccines Consumption Value by Application (2021-2026) & (USD Million)
Table 120. Global Aujeszky Disease Vaccines Consumption Value by Application (2027-2032) & (USD Million)
Table 121. Global Aujeszky Disease Vaccines Average Price by Application (2021-2026) & (US$/Dose)
Table 122. Global Aujeszky Disease Vaccines Average Price by Application (2027-2032) & (US$/Dose)
Table 123. North America Aujeszky Disease Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 124. North America Aujeszky Disease Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 125. North America Aujeszky Disease Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 126. North America Aujeszky Disease Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 127. North America Aujeszky Disease Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 128. North America Aujeszky Disease Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 129. North America Aujeszky Disease Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 130. North America Aujeszky Disease Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 131. Europe Aujeszky Disease Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 132. Europe Aujeszky Disease Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 133. Europe Aujeszky Disease Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 134. Europe Aujeszky Disease Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 135. Europe Aujeszky Disease Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 136. Europe Aujeszky Disease Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 137. Europe Aujeszky Disease Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 138. Europe Aujeszky Disease Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 140. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 141. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 142. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 143. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Region (2021-2026) & (K Dose)
Table 144. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity by Region (2027-2032) & (K Dose)
Table 145. Asia-Pacific Aujeszky Disease Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 146. Asia-Pacific Aujeszky Disease Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 147. South America Aujeszky Disease Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 148. South America Aujeszky Disease Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 149. South America Aujeszky Disease Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 150. South America Aujeszky Disease Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 151. South America Aujeszky Disease Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 152. South America Aujeszky Disease Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 153. South America Aujeszky Disease Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 154. South America Aujeszky Disease Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 155. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 156. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 157. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 158. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 159. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 160. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 161. Middle East & Africa Aujeszky Disease Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 162. Middle East & Africa Aujeszky Disease Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 163. Aujeszky Disease Vaccines Raw Material
Table 164. Key Manufacturers of Aujeszky Disease Vaccines Raw Materials
Table 165. Aujeszky Disease Vaccines Typical Distributors
Table 166. Aujeszky Disease Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Aujeszky Disease Vaccines Picture
Figure 2. Global Aujeszky Disease Vaccines Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Aujeszky Disease Vaccines Revenue Market Share by Type in 2025
Figure 4. Live Attenuated Vaccine Examples
Figure 5. Inactivated Vaccine Examples
Figure 6. Others Examples
Figure 7. Global Aujeszky Disease Vaccines Revenue by Strain Platform, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Aujeszky Disease Vaccines Revenue Market Share by Strain Platform in 2025
Figure 9. Bartha-K61 Strain Examples
Figure 10. HB98 Strain Examples
Figure 11. C Strain Examples
Figure 12. Other Examples
Figure 13. Global Aujeszky Disease Vaccines Revenue by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Aujeszky Disease Vaccines Revenue Market Share by Dose Pack Size in 2025
Figure 15. Small Pack (Below 20 Doses per Vial) Examples
Figure 16. Medium Pack (20–50 Doses per Vial) Examples
Figure 17. Large Pack (Above 50 Doses per Vial) Examples
Figure 18. Global Aujeszky Disease Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Global Aujeszky Disease Vaccines Revenue Market Share by Application in 2025
Figure 20. Large-scale Swine Farming Groups Examples
Figure 21. Breeding Farms Examples
Figure 22. Animal Disease Control Institutions Examples
Figure 23. Others Examples
Figure 24. Global Aujeszky Disease Vaccines Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Aujeszky Disease Vaccines Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Aujeszky Disease Vaccines Sales Quantity (2021-2032) & (K Dose)
Figure 27. Global Aujeszky Disease Vaccines Price (2021-2032) & (US$/Dose)
Figure 28. Global Aujeszky Disease Vaccines Sales Quantity Market Share by Manufacturer in 2025
Figure 29. Global Aujeszky Disease Vaccines Revenue Market Share by Manufacturer in 2025
Figure 30. Producer Shipments of Aujeszky Disease Vaccines by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 31. Top 3 Aujeszky Disease Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 32. Top 6 Aujeszky Disease Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 33. Global Aujeszky Disease Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 34. Global Aujeszky Disease Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 35. North America Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 37. Asia-Pacific Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 38. South America Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 39. Middle East & Africa Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 40. Global Aujeszky Disease Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 41. Global Aujeszky Disease Vaccines Consumption Value Market Share by Type (2021-2032)
Figure 42. Global Aujeszky Disease Vaccines Average Price by Type (2021-2032) & (US$/Dose)
Figure 43. Global Aujeszky Disease Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 44. Global Aujeszky Disease Vaccines Revenue Market Share by Application (2021-2032)
Figure 45. Global Aujeszky Disease Vaccines Average Price by Application (2021-2032) & (US$/Dose)
Figure 46. North America Aujeszky Disease Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 47. North America Aujeszky Disease Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 48. North America Aujeszky Disease Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 49. North America Aujeszky Disease Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 50. United States Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe Aujeszky Disease Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 54. Europe Aujeszky Disease Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 55. Europe Aujeszky Disease Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 56. Europe Aujeszky Disease Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 58. France Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 63. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 64. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 65. Asia-Pacific Aujeszky Disease Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 66. China Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 69. India Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Aujeszky Disease Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 73. South America Aujeszky Disease Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 74. South America Aujeszky Disease Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 75. South America Aujeszky Disease Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 76. Brazil Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 77. Argentina Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 78. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 79. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 80. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 81. Middle East & Africa Aujeszky Disease Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 82. Turkey Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 83. Egypt Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 85. South Africa Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 86. Aujeszky Disease Vaccines Market Drivers
Figure 87. Aujeszky Disease Vaccines Market Restraints
Figure 88. Aujeszky Disease Vaccines Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. Manufacturing Cost Structure Analysis of Aujeszky Disease Vaccines in 2025
Figure 91. Manufacturing Process Analysis of Aujeszky Disease Vaccines
Figure 92. Aujeszky Disease Vaccines Industrial Chain
Figure 93. Sales Channel: Direct to End-User vs Distributors
Figure 94. Direct Channel Pros & Cons
Figure 95. Indirect Channel Pros & Cons
Figure 96. Methodology
Figure 97. Research Process and Data Source
Figure 1. Aujeszky Disease Vaccines Picture
Figure 2. Global Aujeszky Disease Vaccines Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Aujeszky Disease Vaccines Revenue Market Share by Type in 2025
Figure 4. Live Attenuated Vaccine Examples
Figure 5. Inactivated Vaccine Examples
Figure 6. Others Examples
Figure 7. Global Aujeszky Disease Vaccines Revenue by Strain Platform, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Aujeszky Disease Vaccines Revenue Market Share by Strain Platform in 2025
Figure 9. Bartha-K61 Strain Examples
Figure 10. HB98 Strain Examples
Figure 11. C Strain Examples
Figure 12. Other Examples
Figure 13. Global Aujeszky Disease Vaccines Revenue by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Aujeszky Disease Vaccines Revenue Market Share by Dose Pack Size in 2025
Figure 15. Small Pack (Below 20 Doses per Vial) Examples
Figure 16. Medium Pack (20–50 Doses per Vial) Examples
Figure 17. Large Pack (Above 50 Doses per Vial) Examples
Figure 18. Global Aujeszky Disease Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Global Aujeszky Disease Vaccines Revenue Market Share by Application in 2025
Figure 20. Large-scale Swine Farming Groups Examples
Figure 21. Breeding Farms Examples
Figure 22. Animal Disease Control Institutions Examples
Figure 23. Others Examples
Figure 24. Global Aujeszky Disease Vaccines Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Aujeszky Disease Vaccines Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Aujeszky Disease Vaccines Sales Quantity (2021-2032) & (K Dose)
Figure 27. Global Aujeszky Disease Vaccines Price (2021-2032) & (US$/Dose)
Figure 28. Global Aujeszky Disease Vaccines Sales Quantity Market Share by Manufacturer in 2025
Figure 29. Global Aujeszky Disease Vaccines Revenue Market Share by Manufacturer in 2025
Figure 30. Producer Shipments of Aujeszky Disease Vaccines by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 31. Top 3 Aujeszky Disease Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 32. Top 6 Aujeszky Disease Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 33. Global Aujeszky Disease Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 34. Global Aujeszky Disease Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 35. North America Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 37. Asia-Pacific Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 38. South America Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 39. Middle East & Africa Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 40. Global Aujeszky Disease Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 41. Global Aujeszky Disease Vaccines Consumption Value Market Share by Type (2021-2032)
Figure 42. Global Aujeszky Disease Vaccines Average Price by Type (2021-2032) & (US$/Dose)
Figure 43. Global Aujeszky Disease Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 44. Global Aujeszky Disease Vaccines Revenue Market Share by Application (2021-2032)
Figure 45. Global Aujeszky Disease Vaccines Average Price by Application (2021-2032) & (US$/Dose)
Figure 46. North America Aujeszky Disease Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 47. North America Aujeszky Disease Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 48. North America Aujeszky Disease Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 49. North America Aujeszky Disease Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 50. United States Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe Aujeszky Disease Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 54. Europe Aujeszky Disease Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 55. Europe Aujeszky Disease Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 56. Europe Aujeszky Disease Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 58. France Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 63. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 64. Asia-Pacific Aujeszky Disease Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 65. Asia-Pacific Aujeszky Disease Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 66. China Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 69. India Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Aujeszky Disease Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 73. South America Aujeszky Disease Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 74. South America Aujeszky Disease Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 75. South America Aujeszky Disease Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 76. Brazil Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 77. Argentina Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 78. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 79. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 80. Middle East & Africa Aujeszky Disease Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 81. Middle East & Africa Aujeszky Disease Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 82. Turkey Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 83. Egypt Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 85. South Africa Aujeszky Disease Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 86. Aujeszky Disease Vaccines Market Drivers
Figure 87. Aujeszky Disease Vaccines Market Restraints
Figure 88. Aujeszky Disease Vaccines Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. Manufacturing Cost Structure Analysis of Aujeszky Disease Vaccines in 2025
Figure 91. Manufacturing Process Analysis of Aujeszky Disease Vaccines
Figure 92. Aujeszky Disease Vaccines Industrial Chain
Figure 93. Sales Channel: Direct to End-User vs Distributors
Figure 94. Direct Channel Pros & Cons
Figure 95. Indirect Channel Pros & Cons
Figure 96. Methodology
Figure 97. Research Process and Data Source
